(-)-Epicatechin

(-)-Epicatechin is a lipid of Polyketides (PK) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 55698 references associated with (-)-Epicatechin in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for (-)-Epicatechin

PubChem Biomolecular Interactions and Pathways

NCBI Entrez Crosslinks

All references with (-)-Epicatechin

Download all related citations
Per page 10 20 50 100 | Total 8500
Authors Title Published Journal PubMed Link
Xie D et al. (-)-Epigallocatechin-3-gallate protects cultured spiral ganglion cells from H2O2-induced oxidizing damage. 2004 Acta Otolaryngol. pmid:15224876
Kumar S et al. Antioxidant and free radical scavenging potential of Citrullus colocynthis (L.) Schrad. methanolic fruit extract. 2008 Acta Pharm pmid:18515231
Scalia S et al. In vivo human skin penetration of (-)-epigallocatechin-3-gallate from topical formulations. 2014 Acta Pharm pmid:24914725
Rudolfová P et al. Effect of selected catechins on doxorubicin antiproliferative efficacy and hepatotoxicity in vitro. 2014 Acta Pharm pmid:24914720
Siegers CP et al. Influence of dithiocarb, (+)-catechin and silybine on halothane hepatotoxicity in the hypoxic rat model. 1983 Acta Pharmacol Toxicol (Copenh) pmid:6312740
Yang D et al. Epigallocatechin gallate inhibits angiotensin II-induced endothelial barrier dysfunction via inhibition of the p38 MAPK/HSP27 pathway. 2010 Acta Pharmacol. Sin. pmid:20644550
Zhen MC et al. Green tea polyphenol epigallocatechin-3-gallate suppresses rat hepatic stellate cell invasion by inhibition of MMP-2 expression and its activation. 2006 Acta Pharmacol. Sin. pmid:17112415
Jin J et al. Prostanoid EP1 receptor as the target of (-)-epigallocatechin-3-gallate in suppressing hepatocellular carcinoma cells in vitro. 2012 Acta Pharmacol. Sin. pmid:22555372
Chen ZY et al. (-)epicatechin induces and modulates endothelium-dependent relaxation in isolated rat mesenteric artery rings. 2002 Acta Pharmacol. Sin. pmid:12466059
Xu F and Zhen YS (-)-Epigallocatechin-3-gallate enhances anti-tumor effect of cytosine arabinoside on HL-60 cells. 2003 Acta Pharmacol. Sin. pmid:12546725